C. Perusquía-Hernández et al. / Tetrahedron Letters 54 (2013) 3302–3305
3305
1
27.3 (CH), 127.9 (CH), 128.3 (CH), 128.7 (CH), 129.3 (CH), 130.0 (CH), 131.9 127.8, (CH), 128.1 (CH), 128.8 (CH), 129.3 (CH), 129. 8 (CH), 131.8 (CH), 133.8
+
+
+
+
(
C), 134.2 (C), 138.236 (C),168. 3 (C); MS [EI ] m/z (RI%): 288 [M] (10); IR:
(C), 134.25 (C), 139.2 (C),166. 35 (C); [EI ] m/z (RI%): 322 [M] (10); IR: (ATR,
À1
1
À1
cm ) 1715. Compound 15: 1H NMR (500 MHz, CDCl
(
ATR, cm ) 1690, 1650. Compound 5: H NMR (CDCl
3
, 500 MHz) d: 7.14 (s, 1H,
, 125 MHz) d 78.5
CH), 123.6 (CH), 127.1 (CH), 128.3 (CH), 128.3 (CH), 128.7 (CH), 130.7 (CH)
3
) d 2.15 (s, 3H), 5.09 (s,
1
3
13
CH) 7.28–7.48 (m, 12H), 7.89 (d, J = 8 Hz, 2H). C NMR (CDCl
(
3
2H), 7.56 (d, J = 8.2 Hz, 1H), 8.05 (dd, J = 8.2 Hz, 2H). C NMR (127.5 MHz,
CDCl ) d 21.5 (CH ), 65.9 (CH
), 128.5 (2ÂCH), 128.9 (2ÂCH), 134.2 (C), 135.2
(C), 170.1 (C); [EI ] m/z (RI%): 184 [M] (20); IR: (ATR, cm ) 1735. Compound
16: 1H NMR (500 MHz, CDCl
) d 5.30 (s, 2H), 7.34 (m, 4H), 7.41 (m, 2H), 7.56 (d,
J = 7.4 Hz, 1H), 8.05 (dd, J = 8.4 Hz, 2H). C NMRNMR (127.5 MHz, CDCl
65.9 (CH
3
3
+
2
+
À1
1
30.8 (CH), 132.4 (CH), 135.5 (CH), 137.6 (CH), 139.5 (CH), 140.2 (CC), 150.6
+
+
À1
(
CH), 163.7 (C), 176.7 (C); MS [EI ] m/z (RI%): 333 [M] (7); IR: (ATR, cm
)
3
1
13
1
720, 1526, 1493, 1277, 1138. Compound 6: H NMR (CDCl
3
, 500 MHz) d: 7.16
3
) d
1
3
(
s, 1H), 7.23–7.82 (m, 12H), 8.47 (m, 1H), 8.96 (m, 1H). C NMR (CDCl
3
,
2
), 128.5 (2ÂCH), 128.9 (2ÂCH), 129.6 (2ÂCH), 129.8 (2ÂCH), 130.0
+
+
1
25 MHz) d 79.5 (CH), 123.5 (CH), 126.3 (CH), 128.2 (CH), 129.3 (CH), 129.6
(C), 133.2 (CH), 134.2 (C), 134.7 (C), 166.3 (C). MS [EI ] m/z (RI%): 246 [M] (10);
+
À1
(
[
(
(
CH), 131 (CH) 136 (CH), 140.2 (C), 147.8 (C), 169.8 (C); MS [EI ] m/z (RI%): 333
+
À1
1
M] (10); IR: (ATR, cm ) 1720, 1526, 1493, 1277, 1138. Compound 7:1 H NMR
3
CDCl
CDCl
3
, 500 MHz) d 2.39 (s, 3H) 7.12 (s, 1H) 7.22–7.95 (m, 14H); C NMR
, 125 MHz) d 21.3 (CH ), 77.3 (CH), 127.1 (CH), 127.8 (CH), 127.9 (CH),
28 (CH), 128.2 (CH), 128.3 (CH), 128.5 (CH), 128.6 (CH), 129.3 (CH), 130 (CH),
30.1 (CH) 130.3 (CH), 132.4 (CH) 133.9 (C), 137.6 (C), 138.2 (C), 140.35 (C),
3
3
1
1
1
+
+
À1
65.75 (C); MS [EI ] m/z (RI%): 302 [M] (15); IR: (ATR, cm ) 1719, 1316, 1196.
1
Compound 8: H NMR (CDCl
H), 7.40 (m, 3H), 7.86 (m, 2H); C NMR (CDCl
CH ), 69.9 (CH), 126.5 (CH), 128.3, (CH), 129.5 (CH). 138.4 (C), 168.7 (C); MS
EI+] m/z (RI%): 164 [M] (10); IR: (ATR, cm
3
, 500 MHz) d 1.22 (d, 3H), 2.31 (s, 3H), 3.77 (q,
1
3
1
3 3
, 125 MHz) d 15.0 (CH ), 31.0
(
[
3
+
À1
)
2928, 1741, 1028, 697.
, 500 MHz) d 1.05 (d, 6H), 3.98 (m, 1H), 7.40 (m,
H), 7.89 (m, 2H); 13C NMR (CDCl
, 125 MHz) d 20.7 (CH ), 68.3 (CH), 128.4
CH), 129.5 (CH), 130.1 (CH), 133.6 (C), 172.5 (C); MS [EI ] m/z (RI%): 164 [M]
1
Compound 9: H NMR (CDCl
3
(
3
3
3
+
+
À1
1
(
15); IR: (ATR, cm ) 2964, 1739. Compound 10: H NMR (CDCl
3
, 500 MHz) d
1
3
4
.83 (s, 2H), 7.00 (s, 1H) 7.21–7.80 (m, 17H); C NMR (CDCl , 125 MHz) d 65.5
3
(
1
CH2),77.8 (CH), 107.2 (CH), 118.6 (CH), 124.1 (CH), 126.4 (CH), 126.9 (CH),
27.1 (CH) 127.6 (CH), 128.13 (CH), 128.2 (CH), 128.5 (CH), 129.7 (CH), 130.6
C), 132.4 (CH), 137.6 (CH), 139.4 (CH), 140.5 (C), 157.2 (C), 196.745 (C); MS
33. Selected spectral data. Compound 14: 1H NMR (CDCl
, 500 MHz) d: 0.78 (s, 3H),
0.80 (s, 3H),0.92 (s, 3H), 1.03 (m, 1H), 1.04 (m, 1H), 1.09 (m, 1H), 1.82 (m, 2H),
3
(
[
+
+
À1
13
EI ] m/z (RI%): 368 [M] (5); IR: (ATR, cm ) 1737, 1277, 1173. Compound 11:
1.92 (d, 2H), 2.17 (s, 3H), 4.90 (m, 1H); C NMR (CDCl
3
, 125 MHz) d: 11.2
), 35.2 (CH ), 43.9
1
13
H NMR (CDCl
CDCl , 125 MHz) d 77.5 (CH), 125.3 (CH), 126.7 (CH), 127.2 (CH), 127.8 (CH),
28.0 (CH), 128.2 (CH), 128.2 (CH), 128.3 (CH), 128.6 (CH), 131.3 (CH), 132.4
3
, 500 MHz) d 7.19 (s, 1H) 7.24–8.70 (m, 17H, ArH); C NMR
(CH ), 18.6 (CH ), 19.6 (CH ), 27.3 (CH ), 32.5 (CH ), 32.8 (CH
(CH), 47.8 (C), 52.4 (C), 79.3 (CH), 173. 4 (C); MS [EI ] m/z (RI%): 196 [M] (5);
3
3
3
3
2
2
2
+
+
(
3
À1
1
+
+
(
(
CH), 132.5 (CH), 132.6 (C), 137.2 (C), 165.7 (C); MS [EI ] m/z (RI%): 338 [M]
À1
1
15); IR: (ATR, cm ) 1714, 1278, 1156. Compound 12: H NMR (500 MHz,
) d 2.32 (s, 3H), 7.12 (s, 1H), 7.30 (d, J = 8.4 Hz, 2H), 7.32–7.97 (m, 12 H);
C NMR (CDCl , 125 MHz) d 22.1 (CH ), 77.2 (CH), 127.3 (CH), 127.7 (CH), 1278
CH), 128.1 (CH), 128.3 (CH), 128.5 (CH), 128.6(CH), 128.7 (CH), 129.3 (CH),
CDCl
3
1
3
3
3
(
1
1
1
30.0 (CH), 130.1 (CH) 130.3 (CH), 132.4 (CH) 133.9 (C), 137.6 (C), 138.2 (C),
+
À1
40.35 (C), 165.75 (C); MS [EI+] m/z (RI%): 302 [M] (5); IR: (ATR, cm ) 1720,
1
315, 1196. Compound 13: H NMR (CDCl
3
, 500 MHz) d: 7.15 (s, 1H), 7.31–7.54
, 125 MHz) d: 78.9 (CH), 127.3
CH), 128.1 (CH), 128.8 (CH), 129.3 (CH), 131.5 (CH), 133.9 (C), 134.2 (C), 138.6
1
3
(
(
(
m, 12H), 8.14 (d, J = 8.1 Hz, 2H); C NMR (CDCl
3
+
+
À1
C),166. 35 (C); [EI ] m/z (RI%): 322 [M] (15); IR: (ATR, cm ) 1710; Compound
1
1
8
4: H NMR (CDCl
3
, 500 MHz) d: 7.10 (s, 1H), 7.31–7.67 (m, 12H), 8.02 (m, 1H),
13
.15 (d, J = 8.1 Hz, 1H); C NMR (CDCl , 125 MHz) d: 78.1 (CH), 127.2 (CH),
3